ÅǸ޴º
¹øÈ£ | ±¸ºÐ | Á¦¸ñ |
---|---|---|
263 | (±¹¿Ü)SCI | Oncolytic vaccinia virus reinvigorates peritoneal immunity and cooperates with PD-1 blockade to suppress peritoneal carcinomatosis in colon cancer |
262 | (±¹¿Ü)SCIE | Combination Immunotherapy Using Oncolytic Virus for the Treatment of Advanced Solid Tumors |
261 | (±¹¿Ü)SCI | "Antitumor effects of IL-12 and GM-CSF co-expressed in an engineered oncolytic HSV-1" |
260 | (±¹¿Ü)SCI | "A randomised phase 2b study comparing the efficacy and safety of belotecan vs. topotecan as monotherapy for sensitive-relapsed small-cell lung cancer" |
259 | (±¹¿Ü)SCI | Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity |
258 | (±¹¿Ü)SCI | AXL/MET dual inhibitor, CB469, has activity in non-small cell lung cancer with acquired resistance to EGFR TKI with AXL or MET activation |
257 | (±¹³»)SCIE | "Sonic Hedgehog Pathway as the Prognostic Marker in Patients with Extensive Stage Small Cell Lung Cancer" |
256 | (±¹¿Ü)SCIE | Combined CDK2 and CDK4/6 Inhibition Overcomes Palbociclib Resistance in Breast Cancer by Enhancing Senescence |
255 | (±¹¿Ü)SCI | Preclinical platform for long-term evaluation of immuno-oncology drugs using hCD34+ humanized mouse model |
254 | (±¹³»)SCI | Optimal Voltage and Electrical Pulse Conditions for Electrical Ablation to Induce Immunogenic Cell Death (ICD) |
Copyright ¨Ï chamc, All rights reserved.